To investigate the influence of fibromyalgia (FM) on achieving remission defined on the basis of the Simplified Disease Activity Index (SDAI) remission criteria in patients with long-standing rheumatoid arthritis (RA). This observational longitudinal cohort consisted of long-standing RA patients being treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or biological DMARDs (bDMARDs). After 6 months of follow-up, the patients fulfilling or not fulfilling the remission criteria were identified and compared with each other in terms of the presence of FM, neuropathic pain, and other comorbidities. At the end of the 6-month observation period, 24 of the 117 patients (20.4%) met the SDAI remission criteria. Logistic regression analysis showed that the modified Rheumatic Disease Comorbidity Index (mRDCI) (p = 0.0001), the FM presence (p = 0.0001), and the 36-item short-form health survey Mental Component Summary (SF-36 MCS) Score (p = 0.0088) were the strongest predictors of not being in SDAI remission. None of the patients with concomitant FM (17.1%) achieved SDAI remission. In comparison with the non-FM patients, the patients with RA and FM patients had worse scores on the SF-36 MCS (p = 0.011), on the sleep Visual Analogue Scale (VAS) (p = 0.018), on the self-counts of tender joints (p = 0.039), and on the PainDetect Questionnaire (PDQ) (p = 0.001). To avoid over treatment, an assessment of FM should be considered in RA patients who do not fulfil the remission criteria.

The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis / F. Salaffi, M.C. Gerardi, F. Atzeni, A. Batticciotto, R. Talotta, A. Draghessi, M. Di Carlo, P. Sarzi-Puttini. - In: RHEUMATOLOGY INTERNATIONAL. - ISSN 0172-8172. - 37:12(2017 Dec), pp. 2035-2042. [10.1007/s00296-017-3792-4]

The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis

A. Batticciotto;R. Talotta;P. Sarzi-Puttini
2017

Abstract

To investigate the influence of fibromyalgia (FM) on achieving remission defined on the basis of the Simplified Disease Activity Index (SDAI) remission criteria in patients with long-standing rheumatoid arthritis (RA). This observational longitudinal cohort consisted of long-standing RA patients being treated with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) or biological DMARDs (bDMARDs). After 6 months of follow-up, the patients fulfilling or not fulfilling the remission criteria were identified and compared with each other in terms of the presence of FM, neuropathic pain, and other comorbidities. At the end of the 6-month observation period, 24 of the 117 patients (20.4%) met the SDAI remission criteria. Logistic regression analysis showed that the modified Rheumatic Disease Comorbidity Index (mRDCI) (p = 0.0001), the FM presence (p = 0.0001), and the 36-item short-form health survey Mental Component Summary (SF-36 MCS) Score (p = 0.0088) were the strongest predictors of not being in SDAI remission. None of the patients with concomitant FM (17.1%) achieved SDAI remission. In comparison with the non-FM patients, the patients with RA and FM patients had worse scores on the SF-36 MCS (p = 0.011), on the sleep Visual Analogue Scale (VAS) (p = 0.018), on the self-counts of tender joints (p = 0.039), and on the PainDetect Questionnaire (PDQ) (p = 0.001). To avoid over treatment, an assessment of FM should be considered in RA patients who do not fulfil the remission criteria.
Fibromyalgia; Outcome measures; Remission; Rheumatoid arthritis; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Biological Products; Female; Fibromyalgia; Humans; Logistic Models; Longitudinal Studies; Male; Middle Aged; Pain; Pain Measurement; Quality of Life; Remission Induction; Surveys and Questionnaires; Severity of Illness Index; Rheumatology; Immunology and Allergy; Immunology
Settore MED/16 - Reumatologia
dic-2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
Salaffi2017_Article_TheInfluenceOfFibromyalgiaOnAc.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 710.85 kB
Formato Adobe PDF
710.85 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/640492
Citazioni
  • ???jsp.display-item.citation.pmc??? 8
  • Scopus 37
  • ???jsp.display-item.citation.isi??? 34
social impact